{"id":10851,"date":"2026-05-26T14:43:00","date_gmt":"2026-05-26T12:43:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=8f537c948b11dd159db3e5e464920112"},"modified":"2026-05-26T14:43:00","modified_gmt":"2026-05-26T12:43:00","slug":"tecan-establishes-direct-sales-and-specialist-lab-automation-service-operations-in-india","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=10851","title":{"rendered":"Tecan Establishes Direct Sales and Specialist Lab Automation Service Operations in India"},"content":{"rendered":"<p class=\"bwalignc\">\n<i>Strengthening local presence and customer support in a high-growth life sciences market<\/i><\/p><p>M\u00c4NNEDORF, Switzerland--(BUSINESS WIRE)--Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the launch of direct operations in India, including a dedicated local sales and service team based in Gurugram, near New Delhi. The launch, marked with a ribbon-cutting ceremony, is an important milestone in the company\u2019s geographical expansion and reinforces its commitment to serving customers in one of the world\u2019s most dynamic and fastest-growing life sciences markets.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260526195832\/en\/2814663\/5\/Logo_Tecan.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260526195832\/en\/2814663\/22\/Logo_Tecan.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260526195832\/en\/2814663\/5\/Logo_Tecan.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260526195832\/en\/2814663\/21\/Logo_Tecan.jpg\" \/><\/a><p>\nFor over a decade, Tecan has supported customers in India through its trusted distributor partner Bioscreen. As it establishes a direct presence, Tecan will continue to work with Bioscreen, combining local expertise with closer customer engagement and strengthened support.<\/p><p>\nThe establishment of Tecan India, incorporated on April 1, 2026, brings the company closer to customers across the pharmaceutical, biotechnology, academic and diagnostic sectors, enabling more direct collaboration and responsive local support.<\/p><p>\n<b>Mukta Acharya, EVP and Head of Tecan\u2019s Life Sciences business, said:<\/b> <i>\u201cIndia is a key market for the future of life sciences, with strong momentum across CROs, pharma, biotech and diagnostics. Establishing a direct presence allows us to be closer to our customers, deepen collaboration and further strengthen the value we deliver locally.\u201d<\/i><\/p><p>\nBuilding on its expansion into South Korea in 2024, Tecan is strengthening its presence in high-growth regions as part of its ongoing commitment to improving the lives and health of people. It does this by enabling its customers to scale healthcare innovation globally.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b>Media contact:<\/b><br\/>Dr Ben Rutter\n<br\/>Zyme Communications\n<br\/>Tel: +44 (0) 7920 770 935\n<br\/>Email: <a  href=\"mailto:ben.rutter@zymecommunications.com\" rel=\"nofollow\" shape=\"rect\">ben.rutter@zymecommunications.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Strengthening local presence and customer support in a high-growth life sciences marketM\u00c4NNEDORF, Switzerland&#8211;(BUSINESS WIRE)&#8211;Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the launch of d&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10851","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10851"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10851\/revisions"}],"predecessor-version":[{"id":10852,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10851\/revisions\/10852"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}